Quantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules.

Quantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules.

Epidermal growth factor receptor (EGFR) is often constitutively stimulated in many cancers owing to the binding of ligands such as epidermal growth factor (EGF). Therefore, it is necessary to investigate the interaction between EGFR and its targeting biomolecules. The main aim of this study was to e...

Full description

Bibliographic Details
Main Authors:	Wei-Ting Kuo, Wen-Chun Lin, Kai-Chun Chang, Jian-Yuan Huang, Ko-Chung Yen, In-Chi Young, Yu-Jun Sun, Feng-Huei Lin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4344348?pdf=render

Similar Items

Correction: quantitative analysis of ligand-EGFR interactions: a platform for screening targeting molecules.
by: Wei-Ting Kuo, et al.
Published: (2015-01-01)

Monoclonal Antibody Ligand Mediated Gelatin Nanoparticles Targeting to EGFR for Lung Cancer Therapy
by: Wen-Chun Lin, et al.
Published: (2010)

Screening of Small Molecule Microarrays for Ligands Targeted to the Extracellular Epitopes of Living Cells
by: Jeong Heon Lee, et al.
Published: (2015-02-01)

Biomarker and Therapeutic Studies of Antibodies and Small Molecules that Target EGFR
by: Mutsaers, Anthony James
Published: (2010)

Biomarker and Therapeutic Studies of Antibodies and Small Molecules that Target EGFR
by: Mutsaers, Anthony James
Published: (2010)

EGFR- and HER2-Binding Affibody Molecules : Cellular studies of monomeric, dimeric and bispecific ligands
by: Ekerljung, Lina
Published: (2011)

Heptameric targeting ligands against EGFR and HER2 with high stability and avidity.
by: Dongwook Kim, et al.
Published: (2012-01-01)

Single-Molecule Super-Resolution Microscopy Reveals Heteromeric Complexes of MET and EGFR upon Ligand Activation
by: Marie-Lena I.E. Harwardt, et al.
Published: (2020-04-01)

Characterisation and regulation of the Egfr/Egfr ligand system in fish models for melanoma
by: Laisney, Juliette Agnès Geneviève Claire
Published: (2010)

Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors
by: Felix Oh, et al.
Published: (2020-06-01)

Ligand-induced transmembrane conformational coupling in monomeric EGFR
by: Carraway, K.L., III, et al.
Published: (2022)

ADAMs as EGFR ligand sheddases in prostate cancer
by: Willems, Sofie Henriëtte
Published: (2011)

Editorial: Interactions Between Small Molecule Ligands and Target Enzymes
by: Sung-Kun Kim, et al.
Published: (2021-03-01)

The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization
by: Saleh Ihmaid, et al.
Published: (2018-01-01)

Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules
by: Weizhi Chen MD, et al.
Published: (2019-01-01)

Functional Requirement and Redundancy of Egfr Ligands in Drosophila Development
by: Austin, Christina L.
Published: (2013)

From Toxins Targeting Ligand Gated Ion Channels to Therapeutic Molecules
by: Antoine Taly, et al.
Published: (2011-03-01)

EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis
by: Jeng-Shiuan Tsai, et al.
Published: (2021-09-01)

Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors
by: Yanni Zhu, et al.
Published: (2017-06-01)

Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
by: Oh F, et al.
Published: (2018-09-01)

Magnetic nanoparticles as mediators of ligand-free activation of EGFR signaling.
by: Atul A Bharde, et al.
Published: (2013-01-01)

Targeting Melanocortin and Cholecystokinin Receptors via Multivalent Molecules Bearing Peptide Ligands
by: Nakath Gamlath Ralalage, Dayan Elshan
Published: (2014)

The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma
by: Ping-Chih Hsu, et al.
Published: (2020-02-01)

Targeting EGFR in Esophagogastric Cancer
by: Steven B. Maron, et al.
Published: (2020-12-01)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
by: Fu-Tsai Chung, et al.
Published: (2015-01-01)

High-throughput screen for identifying small molecules that target fungal zinc homeostasis.
by: Claudia Simm, et al.
Published: (2011-01-01)

FRET-based quantitative analysis of feedforward and feedback loops in EGFR signaling and the sensitivity to molecular targeting drugs
by: Fujita, Yoshihisa
Published: (2015)

SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands.
by: Sylwia Huber, et al.
Published: (2017-01-01)

Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics
by: He Qiu-Yan, et al.
Published: (2011-06-01)

Fabrication and Characterization of EGFR-Targeted Indocyanine Green- Mitomycin C-Incorporated Perfluorocarbon Nano-Agents for Photochemotherapy of Bladder Cancer Cells
by: Yu-Chun Lin, et al.
Published: (2018)

Characterization of the Small Compounds -T315 on EGFR Degradation in EGFR-TKI Resistant Lung Adenocarcinoma
by: Kuo-Yen Huang, et al.
Published: (2015)

The synthesis of pyrimidine ketoamide molecules as EGFR inhibitors for cancer treatment.
by: Mathenjwa, Gcine Sindisiwe
Published: (2018)

Colloidal Polymeric Platform for Facile Click-Assisted Ligand Functionalization and Receptor Targeting
by: Ruhani Singh, et al.
Published: (2016-12-01)

Complementary approaches to target human respiratory syncytial virus using small molecule ligands
by: Lardeau, Charles-Hugues Claude Jean
Published: (2012)

Correction: Magnetic Nanoparticles as Mediators of Ligand-Free Activation of EGFR Signaling
by: Atul A. Bharde, et al.
Published: (2013-01-01)

Distinct effects of EGFR ligands on human mammary epithelial cell differentiation.
by: Chandrani Mukhopadhyay, et al.
Published: (2013-01-01)

Correction: Magnetic Nanoparticles as Mediators of Ligand-Free Activation of EGFR Signaling.
by: Atul A. Bharde, et al.
Published: (2013-01-01)

THE PHARMACOGENOMICS OF EGFR-DEPENDENT NSCLC: PREDICTING AND ENHANCING RESPONSE TO TARGETED EGFR THERAPY
by: Balko, Justin M.
Published: (2009)

A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density.
by: Bethany Powell Gray, et al.
Published: (2013-01-01)

Update on Anti-EGFR Targeted Therapy
by: Lori Wirth, et al.
Published: (2009-01-01)